Clinical TrialID 927
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
NCT01469182
Allergy
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 927
- Evidence Id
- 927
- Core Evidence Id
- 927
- Source Clinical Trial Id
- 909
- Herb2 Clinical Trial Id
- HBCT000909
- Nct Id
- NCT01469182
- Title
- A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
- Status
- Completed
- Phase
- Phase 3
- Study Result
- Yes
- Study Condition
- Allergy
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- BIOLOGICAL: SCH 39641|DRUG: Placebo for SCH 39641
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 914
- Outcome Measure
- Number of Participants With Treatment-emergent Adverse Events (AEs), Participants were treated for 28 days with either SCH 39641 12 Amb a 1-U or placebo, and the number with treatment-emergent AEs were recorded. An AE is any unfavorable and unintended sign, symptom or disease temporarily associated with the use of a medicinal product, whether or not considered related to the medicinal product. Treatment-emergent AEs are new AEs that occur after participants have been randomized into the trial, or existing AEs that occurred during Screening that increase in severity after randomization., Up to Day 35
- Sponsor Collaborator
- ALK-Abelló A/S
- Funded By
- INDUSTRY
- Location
- Other Id
- P05751|MK-3641
- Start Date
- 2011-11
- Primary Completion Date
- 2012-04
- Completion Date
- 2012-04
- First Posted
- 2011-11-10
- Results First Posted
- 2014-06-05
- Last Update Posted
- 2017-03-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01469182
- Title Cn
- Title En
- A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
- Bilingual Status
- semi_complete